These 3 Stocks Just Bounced From Lows — What Wall Street Thinks Comes Next

Core Insights - Three stocks, Trade Desk (TTD), Moderna (MRNA), and Strategy (MSTR), have recently bounced from lows, but analyst consensus shows differing levels of conviction regarding their recoveries [1] Group 1: Trade Desk (TTD) - Trade Desk rebounded 24.38% to $29.79 but remains 55.23% below its price from a year ago [1] - Of 38 analysts, 16 rate it Buy, 3 Strong Buy, 15 hold a neutral view, and 4 are negative, indicating a split sentiment [1] - Q4 2025 adjusted EPS was $0.59, beating estimates by 73.58%, while revenue of $846.79 million exceeded the consensus of $839.55 million [1] - Q1 2026 guidance suggests revenue of at least $678 million, implying roughly 10% growth, down from 18% in full-year 2025 [1] Group 2: Moderna (MRNA) - Moderna surged 82.54% year-to-date to $53.83, significantly above the consensus price target of $42.90, which is about 20% lower than current trading levels [1] - Among 24 analysts, 18 rate it Hold, 2 Sell, and 2 Strong Sell, indicating skepticism in the analyst community [1] - Q4 EPS was $2.11, below the estimate of $2.62, and revenue of $678 million beat the consensus by 10.73% [1] - Full-year revenue declined 40% from 2024, and the FDA's refusal-to-file letter on a flu vaccine removed a key catalyst [1] Group 3: Strategy (MSTR) - Strategy shares bounced to $139.81 but remain 54.69% below last year's price [1] - Analyst sentiment is the most bullish among the three, with 13 of 14 analysts rating it Buy or Strong Buy, and a consensus target of $394.38, implying 182% upside [1] - The company holds 713,502 BTC, and the Q4 net loss of $12.44 billion was primarily due to a $17.44 billion unrealized loss on digital assets [1] - Subscription services in the underlying software business grew 62.1% year-over-year [1]